SCHEMBL9326201

SCHEMBL9326201

CCOc1ccc(OC(=O)NC)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.62
NQO1 P15559 1/20 0.54
KMT2A Q03164 5/20 0.53
MEN1 O00255 3/20 0.53
CYP1A2 P05177 2/20 0.53
LMNA P02545 2/20 0.53
POLB P06746 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
PARP10 Q53GL7 1/20 0.52
ALDH1A1 P00352 2/20 0.51
CYP3A4 P08684 1/20 0.51
GAA P10253 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
NPC1 O15118 2/20 0.49
RAB9A P51151 1/20 0.49
MAPT P10636 1/20 0.49
FAAH O00519 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12893245 0.85 ALDH1A1 (0.51) PLK1KMT2AMEN1LMNAALDH1A1
SCHEMBL9327664 0.85 PLK1 (0.65) PLK1KMT2ACYP1A2LMNACYP2C19
SCHEMBL28331319 0.82 ACHE (0.51) PLK1KMT2AMEN1LMNAALDH1A1
SCHEMBL12414160 0.81 GAA (0.49) PLK1ALDH1A1GAAMAPTFAAH
SCHEMBL12418675 0.81 ALDH1A1 (0.44) PLK1KMT2ACYP1A2LMNAALDH1A1
SCHEMBL9326256 0.81 RAB9A (0.63) PLK1CYP1A2LMNAPOLBTDP1
SCHEMBL13944297 0.81 KMT2A (0.54) KMT2AMEN1CYP1A2POLBGAA
SCHEMBL14863997 0.80 ALDH1A1 (0.43) PLK1KMT2ACYP1A2LMNAALDH1A1
SCHEMBL12417397 0.80 MAPT (0.51) PLK1ALDH1A1RAB9AMAPTFAAH
SCHEMBL3419802 0.79 NQO1 (0.64) PLK1NQO1KMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9446139-B2 Polymer-based compositions and conjugates of HIV entry inhibitors NEKTAR THERAPEUTICS (US) 2016-09-20 US disclosed
US-20110171160-A1 POLYMER CONJUGATES OF KISS1 PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-14 US disclosed
US-20110165113-A1 POLYMER CONJUGATES OF V681-LIKE PEPTIDES NEKTAR THERAPEUTICS (US) 2011-07-07 US disclosed
US-5365691-A Methods and agents for combating cockroaches BAYER AKTIENGESELLSCHAFT (DE) 1994-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171160-A1 POLYMER CONJUGATES OF KISS1 PEPTIDES KISS1R, PROKR1, NGLY1 PLK1 754/4885NQO1 4217/4885KMT2A 1351/4885
US-20110165113-A1 POLYMER CONJUGATES OF V681-LIKE PEPTIDES NGLY1, VIP, DNPEP PLK1 1701/4885NQO1 4153/4885KMT2A 4161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.